Evidence map›Paper›PMID 36210147›Full record

ArticleCurrent topics in membranes2022

The role of TRPV4 channels in cutaneous epithelia.

Carlene Moore

Open access · greenAbstract read
In one paragraph

Article in Current topics in membranes, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
7.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 16 citations in OpenAlex.

  1. TRPV4 mediates low-humidity responses in epidermal keratinocytes.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  2. Review
  3. Itching, Ionic Channels, Immune System, Magnesium and Antioxidants.Clinical, cosmetic and investigational dermatology · 2026
    Review
  4. Review
  5. TRP Channels in Skin Cancer: Focus on Malignant Melanoma.International journal of molecular sciences · 2025
    Review
  6. Article
  7. Review
  8. The role of TRPV4 in programmed cell deaths.Molecular biology reports · 2024
    Review
  9. Tigliane Diterpenoids.Progress in the chemistry of organic natural products · 2024
    Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Carlene MooreDivision of Headache and Division of Translational Brain Sciences, Department of Neurology, Duke University School of Medicine, Durham, NC, United States. Electronic address: carlene.moore@duke.edu.
Duke University · US

Funding

Institutional Career Development CoreKL2TR002554 · NCATS · DUKE UNIVERSITY · PI SVETKEY, LAURA P · 2018 to 2022
$8.2M
Molecular and Cellular signaling mechanisms of TRPV4 in non-neuronal cells: a pathophysiological relevance for migraine pain.K01NS121195 · NINDS · DUKE UNIVERSITY · PI Carlene D Moore · 2022 to 2026
$955k
NCATS NIH HHS KL2 TR002554NINDS NIH HHS K01 NS121195
6 · The paper itself

Abstract

Transient receptor potential vanilloid 4 (TRPV4) channels are multi-modally activated cation permeable channels that are expressed most organ tissues including the skin. TRPV4 is highly expressed in the skin and functions in skin resident cells such as epidermal keratinocytes, melanocytes, immune mast cells and macrophages, and cutaneous neurons. TRPV4 plays many crucial roles in skin homeostasis to affect an extensive range of processes such as temperature sensation, osmo-sensation, hair growth, cell apoptosis, skin barrier integrity, differentiation, nociception and itch. Since TRPV4 functions in a plenitude of pathological states, TRPV4 can become a versatile therapeutic target for diseases such as chronic pain, itch and skin cancer.

Indexed as

Transient Receptor Potential ChannelsHumansKeratinocytesPruritusSkinTRPV Cation ChannelsTransient Receptor Potential ChannelsTRPV4 protein, humanTRPV Cation ChannelsBarrier functionItchMechanotransductionPainTRPTRPV4UVB photodermatitis

Identifiers

PMID36210147
PMCPMC9990182
OpenAlexW4289114967

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.